SCHEMBL26038

SCHEMBL26038

CCCC(C)CC(C)CCO

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.57
TRPA1 O75762 1/20 0.43
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
LMNA P02545 1/20 0.32
OPRM1 P35372 1/20 0.31
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23561576 0.97 TSHR (0.55) TSHRTRPA1ALDH1A1ALOX15LMNA
SCHEMBL8008044 0.88
SCHEMBL7755334 0.88 TSHR (0.63) TSHRTRPA1ALDH1A1ALOX15LMNA
SCHEMBL8013962 0.88
SCHEMBL497428 0.88
SCHEMBL8604366 0.88 TRPA1 (0.50) TSHRTRPA1ALDH1A1ALOX15TDP1
SCHEMBL1659013 0.86 TSHR (0.60) TSHRTRPA1ALDH1A1ALOX15LMNA
SCHEMBL27545675 0.86
SCHEMBL4269680 0.85 TSHR (0.56) TSHROPRM1CHRM1AKR1A1CHRM3
SCHEMBL1658900 0.84 TSHR (0.52) TSHRTRPA1ALDH1A1LMNACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803309-B Odorous compounds and process for their preparation 丝趣科尔卡有限公司 2024-10-11 CN claimed
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof S.H. Kelkar and Company Limited (IN) 2024-08-08 US claimed
EP-4298078-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. Kelkar and Company Limited (IN) 2024-01-03 EP claimed
CN-115803309-A Odorous compounds and methods of making the same 丝趣科尔卡有限公司 2023-03-14 CN claimed
WO-2022180642-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. KELKAR AND COMPANY LIMITED (IN) 2022-09-01 WO claimed
US-12516012-B2 Odorous compounds and method of preparation thereof S.H. Kelkar and Company Limited (IN) 2026-01-06 US disclosed
US-20250188376-A1 SUSTAINABLE AVIATION FUELS SARTEC CORPORATION 2025-06-12 US disclosed
CN-115803309-B Odorous compounds and process for their preparation 丝趣科尔卡有限公司 2024-10-11 CN disclosed
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof S.H. Kelkar and Company Limited (IN) 2024-08-08 US disclosed
EP-4298078-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. Kelkar and Company Limited (IN) 2024-01-03 EP disclosed
CN-115803309-A Odorous compounds and methods of making the same 丝趣科尔卡有限公司 2023-03-14 CN disclosed
WO-2022180642-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S. H. KELKAR AND COMPANY LIMITED (IN) 2022-09-01 WO disclosed
WO-1998051770-A1 CLEANING COMPOSITION CONTAINING PINE OIL EXTENDERS EXXON CHEMICAL PATENTS INC. (US) 1998-11-19 WO disclosed
WO-1998023637-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-04 WO disclosed
WO-1998022498-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-28 WO disclosed
EP-0788511-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-13 EP disclosed
WO-1996011210-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-18 WO disclosed
EP-0351615-B1 PROCESS FOR THE PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF Aktiengesellschaft (DE) 1992-10-28 EP disclosed
US-5072034-A PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed
EP-0351615-A1 Process for the preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids BASF Aktiengesellschaft (DE) 1990-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240262776-A1 Odorous Compounds and Method of Preparation Thereof OR10J3, OR51E2, DECR1 TSHR 3830/4885TRPA1 7/4885ALDH1A1 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.